Quantcast

Latest Pharmaceutical industry in India Stories

2014-01-08 12:29:08

LONDON, Jan. 8, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global Dermatophytic Onychomycosis Therapeutics Market 2012-2016 TechNavio's analysts forecast the Global Dermatophytic Onychomycosis Therapeutics market to grow at a CAGR of 7.28 percent over the period 2012-2016. One of the key factors contributing to this market growth is the strong and promising pipeline. The Global Dermatophytic Onychomycosis Therapeutics market has also been...

2014-01-08 08:29:06

SHANGHAI, Jan. 8, 2014 /PRNewswire/ -- Eddingpharm today announced that an asset purchase agreement (APA) has been signed with ACT Biotech, Inc. (ACT Biotech), a biopharmaceutical company based in the United States. Eddingpharm acquired worldwide rights to three small molecule drug assets (Telatinib, ACTB1003, and ACTB1010) and other molecules from ACT Biotech. Eddingpharm made an upfront payment to ACT Biotech upon the closing of the transactions contemplated under the APA. ACT...

2014-01-07 08:29:50

INDIANAPOLIS, Jan. 7, 2014 /PRNewswire/ -- -- 2014 revenue anticipated to be between $19.2 billion and $19.8 billion. -- Earnings per share for 2014 are expected to be in the range of $2.77 - $2.85, reflecting the impact of patent expirations. -- 2014 net income and operating cash flow goals of $3.0 billion and $4.0 billion, respectively, are expected to be achieved. -- Company reaffirms commitment to maintain dividend at least at current level....

2014-01-06 08:25:28

WESTBOROUGH, Mass., Jan. 6, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President and Chief Executive Officer, Dr. Geert Cauwenbergh, will present at the Biotech Showcase(TM) 2014 conference on Tuesday, January 14, 2014 at 9:30AM PST. Dr. Cauwenbergh will...

2013-12-18 23:20:25

The Research and Development industry is projected to see continual investment increases over the next five years, primarily in the chemical and life science industries. Avomeen Analytical Services remarks on these findings and some of the underlying causes for the R&D increase, including competitive product design, private funding, and patents. (PRWEB) December 18, 2013 End of the year reports show that, overall, 2013 research and development (R&D) expenditures have stayed...

2013-12-07 23:04:00

Kalen Biomedical's premium lipoprotein products are now available for cardiovascular researchers located in India through the marketing and distribution expertise provided by Biogenuix Medsystems. Montgomery Village, MD (PRWEB) December 07, 2013 Kalen Biomedical, LLC (http://www.kalenbiomed.com) is pleased to announce a distribution agreement with Biogenuix Medsystems in India. Kalen Biomedical, LLC is pleased work with Biogenuix to offer premium lipoprotein products to cardiovascular...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related